Latest Breaking News On - Anti vegf - Page 5 : comparemela.com

On January 28, 2022, the Food and Drug Administration (FDA) approved Genentech's VABYSMO (faricimab-svoa) for the treatment of wet age-related macular degeneration (wAMD) and diabetic macular edema (DME).

Drug administrationAnti vegfLife sciencesFood and drugs lawLife sciencesIotechnology amp nanotechnology